Explorations & Innovations

Current trends in transplantation tacrolimus therapy, drug monitoring, and patient quality of life

Time:
Tuesday, November 6th
10:00 a.m. CDT (Chicago, US )

Free Registration

This webcast is translated in Spanish, German, Portuguese, French, Italian, and Traditional Mandarin.
– Se traducirá este webcast simultáneamente en Español.
– Der Web-Cast findet mit deutscher Simultanűbersetzung statt.
– Esta conferência, via WEB, terá tradução simultânea em Português.
– Cette conférence INTERNET sera traduite simultanément en Français.
– Questa webcast sará disponibile anche con traduzione simultanea in italiano.

Speaker

Prof Pierre Wallemacq, PhD, EurClinChem
Head of the Lab of Analytical Biochemistry, Cliniques Univ St Luc, Université Catholique de Louvain, Brussels

Learning Objectives

Describe briefly the current methods for induction and maintenance therapy for kidney, liver, heart, and lung transplant recipients.
Describe the methods used to monitor patients for both rejection and side effects.
Describe the current laboratory methods used for TDM and the strengths and weaknesses of each analytical method.
Explain the differences between AUC and trough monitoring of patients and when AUC measurements are necessary.
Recognize IS therapy side effects and how to minimize these effects to improve long term graft survival and quality of life.